Study says duplilumab reduces mortality from COVID-19 - News-Medical.Net

A recent report posted to the medRxiv* preprint server assessed the efficacy of dupilumab in blocking the IL-13 signaling pathway and its efficacy in reducing the COVID-19 associated mortality.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), continues to plague the globe. Many approaches involve targeting inflammation … [+4532 chars]

full article...